See more : RailTel Corporation of India Limited (RAILTEL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Elevance Health Inc. (ANTM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Elevance Health Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Fortescue Metals Group Limited (FMG.AX) Income Statement Analysis – Financial Results
- CAPITA Inc. (7462.T) Income Statement Analysis – Financial Results
- Coromandel Engineering Company Limited (COROENGG.BO) Income Statement Analysis – Financial Results
- Videndum Plc (VID.L) Income Statement Analysis – Financial Results
- Biotech Acquisition Company (BIOT) Income Statement Analysis – Financial Results
Elevance Health Inc. (ANTM)
About Elevance Health Inc.
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2021, it served 45 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 171.34B | 156.60B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.98B | 79.24B | 73.92B | 71.12B | 61.54B | 60.80B | 58.84B | 61.64B | 62.46B | 61.39B | 57.01B | 45.15B | 20.82B | 16.77B | 13.28B | 10.44B | 17.31B | 12.35B | 11.07B |
Cost of Revenue | 17.29B | 116.64B | 102.65B | 88.05B | 81.79B | 71.90B | 72.24B | 66.83B | 61.12B | 56.85B | 56.24B | 48.21B | 47.65B | 44.93B | 46.99B | 48.21B | 46.44B | 42.52B | 33.51B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 154.05B | 39.95B | 35.99B | 33.82B | 22.43B | 20.21B | 17.80B | 18.14B | 18.12B | 17.07B | 14.89B | 13.32B | 13.16B | 13.91B | 14.65B | 14.25B | 14.96B | 14.49B | 11.64B | 0.00 | 16.77B | 13.28B | 10.44B | 17.31B | 12.35B | 11.07B |
Gross Profit Ratio | 89.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.11B | 2.51B | 1.99B | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 36.24B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.48B | 3.11B | 2.51B | 1.99B | 0.00 | 0.00 | 0.00 |
Other Expenses | 20.09B | 31.50B | 27.05B | 26.11B | 15.69B | 14.37B | 12.82B | 12.72B | 12.76B | 11.97B | 10.20B | 8.91B | 8.68B | 9.08B | 9.71B | 9.29B | 9.00B | 9.13B | 7.51B | 61.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 36.24B | 31.50B | 27.05B | 26.11B | 15.69B | 14.37B | 12.82B | 12.72B | 12.76B | 11.97B | 10.20B | 8.91B | 8.68B | 9.08B | 9.71B | 9.29B | 9.00B | 9.13B | 7.51B | 3.54B | 1.18B | 962.20M | -9.86B | -17.09B | -12.31B | -10.90B |
Cost & Expenses | 37.38B | 148.14B | 129.69B | 114.16B | 97.48B | 86.27B | 85.05B | 79.56B | 73.88B | 68.82B | 66.44B | 57.13B | 56.32B | 54.01B | 56.70B | 57.50B | 55.44B | 51.65B | 41.02B | 19.02B | 15.55B | 12.47B | 9.92B | 17.09B | 12.31B | 10.90B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.03B | 851.00M | 798.00M | 784.00M | 746.00M | 753.00M | 739.00M | 723.00M | 653.00M | 600.70M | 602.70M | 511.80M | 430.30M | 418.90M | 447.60M | 488.90M | 437.10M | 392.40M | 226.70M | 142.30M | 131.20M | 98.50M | 60.20M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.75B | 1.68B | 1.30B | 1.15B | 485.00M | 482.00M | 279.10M | 296.30M | 335.90M | 327.40M | 353.20M | 340.10M | 335.10M | 344.80M | 557.40M | 563.50M | 557.60M | 567.80M | 467.50M | 269.10M | 245.00M | 157.00M | 120.50M | 0.00 | 0.00 | 0.00 |
EBITDA | 10.49B | 10.13B | 6.00B | 8.18B | 7.22B | 0.00 | 77.22B | 5.57B | 5.62B | 5.30B | 4.80B | 0.00 | 4.72B | 5.12B | 8.41B | 4.17B | 6.25B | 5.87B | 4.58B | 1.85B | 1.60B | 255.50M | 645.10M | 17.31B | 12.35B | 11.07B |
EBITDA Ratio | 6.12% | 6.03% | 6.66% | 6.07% | 6.83% | 6.73% | 5.39% | 6.44% | 7.00% | 7.06% | 6.69% | 7.46% | 7.57% | 7.58% | 11.55% | 5.27% | 9.56% | 9.69% | 10.02% | 8.27% | 8.73% | 7.26% | 6.18% | 100.00% | 100.00% | 100.00% |
Operating Income | 133.96B | 8.45B | 8.95B | 7.71B | 6.73B | 5.84B | 4.99B | 5.42B | 5.36B | 5.10B | 4.69B | 4.41B | 4.48B | 4.83B | 4.94B | 4.96B | 5.95B | 5.36B | 4.13B | 1.79B | 1.22B | 807.60M | 524.60M | 17.31B | 12.35B | 11.07B |
Operating Income Ratio | 78.18% | 5.40% | 6.45% | 6.33% | 6.46% | 6.34% | 5.54% | 6.38% | 6.76% | 6.90% | 6.59% | 7.16% | 7.37% | 8.21% | 8.02% | 7.94% | 9.70% | 9.41% | 9.15% | 8.62% | 7.27% | 6.08% | 5.02% | 100.00% | 100.00% | 100.00% |
Total Other Income/Expenses | -126.25B | -851.00M | -1.02B | -1.47B | -748.00M | -769.00M | -73.26B | 2.09B | 2.07B | 1.81B | 1.21B | -511.80M | -523.60M | -479.40M | 2.46B | -1.84B | -696.80M | -448.60M | -241.50M | -350.70M | 775.90M | 0.00 | 524.60M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 7.72B | 7.60B | 7.93B | 6.24B | 5.99B | 5.07B | 3.96B | 4.56B | 4.63B | 4.37B | 3.84B | 3.86B | 3.96B | 4.35B | 7.40B | 3.12B | 5.26B | 4.91B | 3.89B | 1.44B | 1.22B | 807.60M | 524.60M | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 4.50% | 4.85% | 5.72% | 5.12% | 5.74% | 5.50% | 4.40% | 5.36% | 5.84% | 5.91% | 5.40% | 6.27% | 6.51% | 7.40% | 12.01% | 5.00% | 8.56% | 8.62% | 8.62% | 6.93% | 7.27% | 6.08% | 5.02% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 1.72B | 1.71B | 1.83B | 1.67B | 1.18B | 1.32B | 121.00M | 2.09B | 2.07B | 1.81B | 1.21B | 1.21B | 1.31B | 1.47B | 2.66B | 631.70M | 1.91B | 1.82B | 1.43B | 483.20M | 440.10M | 255.20M | 183.40M | -226.00M | -44.90M | -172.40M |
Net Income | 5.99B | 5.89B | 6.10B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B | 2.65B | 2.66B | 2.65B | 2.89B | 4.75B | 2.49B | 3.35B | 3.09B | 2.46B | 960.10M | 774.30M | 549.10M | 342.20M | 226.00M | 44.90M | 172.40M |
Net Income Ratio | 3.49% | 3.76% | 4.40% | 3.75% | 4.61% | 4.07% | 4.27% | 2.91% | 3.23% | 3.48% | 3.73% | 4.32% | 4.35% | 4.91% | 7.70% | 3.99% | 5.45% | 5.43% | 5.46% | 4.61% | 4.62% | 4.13% | 3.28% | 1.31% | 0.36% | 1.56% |
EPS | 25.69 | 24.56 | 25.04 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 | 8.89 | 8.26 | 7.35 | 7.03 | 9.96 | 4.79 | 5.64 | 4.93 | 4.03 | 3.15 | 2.80 | 2.31 | 1.66 | 1.10 | 0.22 | 0.84 |
EPS Diluted | 25.22 | 24.28 | 24.73 | 17.98 | 18.47 | 14.19 | 14.35 | 9.21 | 9.38 | 8.95 | 8.74 | 8.18 | 7.25 | 6.94 | 9.88 | 4.76 | 5.56 | 4.82 | 3.94 | 3.05 | 2.73 | 2.26 | 1.65 | 1.10 | 0.22 | 0.84 |
Weighted Avg Shares Out | 233.07M | 240.00M | 243.80M | 250.80M | 255.50M | 254.30M | 256.08M | 263.75M | 261.24M | 268.11M | 293.27M | 304.72M | 339.37M | 377.74M | 483.20M | 524.30M | 593.40M | 627.77M | 611.36M | 276.51M | 276.54M | 237.71M | 206.77M | 206.18M | 206.18M | 206.18M |
Weighted Avg Shares Out (Dil) | 237.40M | 242.80M | 246.80M | 254.30M | 260.30M | 254.30M | 267.80M | 268.10M | 272.90M | 285.90M | 303.80M | 324.80M | 365.10M | 415.80M | 483.20M | 524.30M | 602.00M | 642.10M | 625.33M | 285.67M | 283.63M | 242.96M | 207.39M | 206.18M | 206.18M | 206.18M |
Anthem Announces Appearance at Upcoming Conference
Former EVP of Anthem Joins MaxHealth as Chief Executive Officer
Here's Why Anthem (ANTM) is a Strong Value Stock
Anthem, Inc. (ANTM) CEO Gail Boudreaux on Q1 2022 Results - Earnings Call Transcript
Anthem (ANTM) Q1 Earnings Beat Estimates, Hikes '22 EPS View
Anthem (ANTM) Tops Q1 Earnings and Revenue Estimates
Anthem Shares Jump On Raised FY22 Outlook Boosted By Better Than Expected Q1 Results
Anthem raises profit forecast on Medicaid boost
Anthem profit, revenue rise well above expectations
Anthem Reports First Quarter 2022 Results, Reflecting Strong Momentum Across All Divisions
Source: https://incomestatements.info
Category: Stock Reports